Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionano Genomics Inc BNGO

Technology Scientific & Technical Instruments
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

Bionano Genome Imaging Concordant with Traditional Cytogenetics in Landmark Leukemia Study

GlobeNewswire February 10, 2020

Users of Bionano Genomics' Saphyr System to Present Reference Genome Assembly and SV Discovery for Plant and Animal Genomes at the PAG XXVIII Conference

GlobeNewswire January 10, 2020

Bionano Genomics' Saphyr® System is Adopted by GeneDx for the Clinical Detection of Genetic Variants in Muscular Dystrophies, Developmental and Reproductive Disorders

GlobeNewswire January 6, 2020

Mayo Clinic Adopts Bionano Saphyr For Applications in Neurodegenerative Diseases

GlobeNewswire December 19, 2019

Breakthrough Findings in Leukemias Presented at ASH 2019 Demonstrate Bionano Saphyr's Potential to Replace All Cytogenetic Methods and Show Additional Clinical Utility

GlobeNewswire December 5, 2019

Takeaways from AMP 2019 in Baltimore: Users of Bionano's Saphyr System Presented Results from Multiple Studies Demonstrating the System's Utility for a Variety of Disease Indications

GlobeNewswire November 12, 2019

Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business Update

GlobeNewswire November 7, 2019

Novogene Adopts Bionano's Saphyr System Adding Saphyr's Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services

GlobeNewswire November 6, 2019

Bionano Genomics to Report Third Quarter 2019 Financial Results and Host a Conference Call and Webcast on November 7

GlobeNewswire November 4, 2019

Takeaways from ASHG 2019 in Houston: Users of Bionano's Saphyr System Presented Validation Results for FSHD, Repeat Expansion Disorders and Digital Cytogenetics Among a Growing List of Applications of Saphyr in Human Genetics and Cancer Research

GlobeNewswire October 24, 2019

Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering

GlobeNewswire October 21, 2019

Bionano Genomics Announces Adoption of Its Saphyr® System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for Clinical Testing

GlobeNewswire October 16, 2019

Bionano Genomics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

GlobeNewswire September 9, 2019

Bionano Genomics Releases Users' Video Presentations of Preliminary Data Affirming Saphyr's Potential to Replace Traditional Cytogenetics Methods in Certain Blood Cancers

GlobeNewswire August 30, 2019

Preliminary Data Confirm Saphyr's Potential to Replace Traditional Cytogenetics Methods for Detection of Structural Variants in Certain Blood Cancers

GlobeNewswire August 13, 2019

Bionano Genomics Reports Second Quarter 2019 Financial Results and Provides Business Update

GlobeNewswire August 8, 2019

Bionano Genomics to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 8

GlobeNewswire August 2, 2019

Results Presented at ESHG 2019 Showcase the Advantages of Saphyr over Traditional Cytogenetics Methods for the Detection of Structural Variants in Patients with Genetic Disease and Cancer

GlobeNewswire June 17, 2019

Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics Conference

GlobeNewswire June 14, 2019

Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital Cytogenetics

GlobeNewswire June 13, 2019